Oct 1, 2024 | 2024, Investors, Press Releases
more detailsOct 1, 2024 | 2024, Investors, Press Releases
more detailsSep 25, 2024 | 2024, Investors, Press Releases
more detailsSep 25, 2024 | 2024, Investors, Press Releases
more detailsJul 9, 2024 | 2024, Events, Investors, Past Events
Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024. Please contact us at IR@philogen.com or follow the link register to the event.
Recent Comments